Data temporarily unavailable
Unable to load analysis for « - » for now. Try again in a few moments.
Investlytic score: 2/5 criteria met. Data as of 17/09/2026.
- ❌ Price trend failed
- ⚠️ Mixed growth
- ❌ Debt failed
- ✅ P/E passed
- ✅ Correction passed
Price trend
Overall trend (8 years): insufficient progression (less than x1.5).
Price change 2018 → 2019: -18.13%
Price change 2019 → 2020: -12.66%
Price change 2020 → 2021: -15.22%
Price change 2021 → 2022: -21.79%
Price change 2022 → 2023: 8.74%
Price change 2023 → 2024: 38.19%
Price change 2024 → 2025: -7.64%
Price change 2025 → 2026: -14.57%
Price change 2026 (year to date): -13.89%
Financial growth
Revenue CAGR (8 years): 2.06%
Earnings CAGR (8 years): -0.89%
Growth status: positive trend (>1%/yr) in revenue OR earnings, but not both.
Debt
Debt-to-equity ratio: 1.00
Debt/equity > 0.5 (maximum threshold).
P/E (Price/Earnings)
P/E ratio: 5.88
P/E < 25.0 (maximum threshold).
Correction (6 months)
Current correction: 18.73% from the high over 6 months.
Correction between 10.0% and 20.0% (target range).
Criteria of the Investlytic model
- / 5Free with the Investlytic logo. Paste this line into your page: options.
<script src="https://investlytic.co/encart.js" data-symbole="ALFLE.PA" data-lang="en"></script>Price trend
Price & trend
Interactive chart →💰 Dividend
Dividend ranking →⚖️ Comparison with the market
All stocks →| Stock | P/E | Dette/FP | Revenue growth | Rating |
|---|---|---|---|---|
| Fleury Michon S.A. | 6.4 | 1.00 | +2.3 % | 🔒 |
| Bonduelle SCA | 12.7 | 0.97 | +2.3 % | – |
| Savencia S.A. | 9.9 | 0.74 | +4.5 % | – |
Data from the Investlytic screener. The rating of the stock being viewed is reserved for members.
Detailed analysis · Price trend
-
Revenues & profits
Revenue and net income
Financial indicators
Annual financial statements
| Fiscal year | Revenue | Net income | Net margin | EPS | Revenue growth |
|---|